Regulators approve Sanofi takeover of Genzyme

Wed, 10/20/2010 - 7:36am
Mass High Tech: The Journal of New England Technology

French drug maker Sanofi-aventis said Wednesday that U.S. antitrust regulators have given the company the OK, in its pursuit to acquire Genzyme Corp.

Sanofi’s bid of $18.5 billion to purchase the largest biotechnology company in Massachusetts will expire on December 10. Sanofi said that the waiting period required by U.S. regulators has now expired, clearing the way for the takeover, that became hostile earlier this month after Sanofi said Genzyme officials refused to come to the table. Genzyme officials are reportedly looking for a price closer to $80 per share up from the $69 per share that has been offered by the French pharma.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.